Vitronectin modulates human mesenchymal stem cell response to insulin-like growth factor-I and transforming growth factor beta 1 in a serum-free environment

Tissue Engineering - Part A

Volumn 15, Issue 6, 2009, Pages 1415-1426

  Parker, Tony ^a   Upton, Zee ^a   Leavesley, David ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; BIOACTIVITY; CELLS; ELECTRIC DISCHARGE MACHINING; ENZYME ACTIVITY; ENZYME INHIBITION; INSULIN; PEPTIDES; TISSUE;

AGGREGATION EFFECTS; BONE TISSUE; CELL CULTURE MEDIA; CELL TYPES; CLINICAL USE; EXTRACELLULAR MATRIX PROTEIN; FUNCTIONAL EXPRESSION; FUNCTIONAL RESPONSE; GROWTH FACTOR; HUMAN MESENCHYMAL STEM CELLS; HUMAN MESENCHYMAL STEM CELLS (HMSCS); IGF-BINDING PROTEINS; IGFBP-3; IN-VITRO; INSULIN-LIKE GROWTH FACTOR-I; MATRIX METALLOPROTEASE; PROTEASE ACTIVITIES; TRANSFORMING GROWTH FACTOR BETA; VITRONECTIN;

CELL CULTURE;

GELATINASE A; GELATINASE B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VITRONECTIN;

AGED; ARTICLE; CASE REPORT; CELL CULTURE; CELL STRUCTURE; CELL TYPE; CONTROLLED STUDY; ENVIRONMENT; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; METABOLIC ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SERUM;

ANIMALIA;

EID: 66249113879     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2007.0431     Document Type: Article

References (64)

1. Otto, W.R., and Rao, J. Tomorrow's skeleton staff: mesenchymal stem cells and the repair of bone and cartilage. Cell Prolif 37, 97, 2004.
2. Bruder, S.P., Jaiswal, N., and Haynesworth, S.E. Haynesworth. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64, 278, 1997.
3. Jaiswal, N., Haynesworth, S.E., Caplan, A.I., and Bruder, S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64, 295, 1997.
4. Lennon, D.P., Haynesworth, S.E., Arm, D.M., Baber, M.A., and Caplan, A.I. Dilution of human mesenchymal stem cells with dermal fibroblasts and the effects on in vitro and in vivo osteochondrogenesis. Devel Dyn 219, 50, 2000.
5. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
6. Bennett, J.H., Carter, D.H., Alavi, A.L., Beresford, J.N., and Walsh, S. Patterns of integrin expression in a human man-dibular explant model of osteoblast differentiation. Arch Oral Biol 46, 229, 2001.
7. Coelho, M.J., Cabral, A.T., and Fernandes, M.H. Human bone cell cultures in biocompatibility testing. Part I: osteoblastic differentiation of serially passaged human bone marrow cells cultured in a-MEM and in DMEM. Biomaterials 21, 1087, 2000.
8. Coelho, M.J., and Fernandes, M.H. Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, beta- glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 21, 1095, 2000.
9. Young, R.G., Butler, D.L., Weber, W., Caplan, A.I., Gordon, S.L., and Fink, D.J. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 16, 406, 1998.
10. Ponticiello, M.S., Schinagl, R.M., Kadiyala, S., and Barry, F.P. Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. J Biomed Mater Res 52, 246, 2000.
11. Bruder, S.P., Kurth, A.A., Shea, M., Hayes, W.C., Jaiswal, N., and Kadiyala, S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 16, 155, 1998.
12. Bruder, S.P., Kraus, K.H., Goldberg, V.M., and Kadiyala, S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Jt Surg 80, 985, 1998.
13. Federal Register, in 21 CFR Parts 16, 1270 and 1271.
14. Stute, N., Holtz, K., Bubenheim, M., Lange, C., Blake, F., and Zander, A.R. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 32, 1212, 2004.
15. Cenni, E., Ciapetti, G., Pagani, S., Perut, F., Giunti, A., and Baldini, N. Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts. J Periodontol 76, 323, 2005.
16. Yazawa, M., Ogata, H., Nakajima, T., Mori, T., Watanabe, N., and Handa, M. Basic studies on the clinical applications of platelet-rich plasma. Cell Transplant 12, 509, 2003.
17. Weibrich, G., Kleis, W.K., Hafner, G., and Hitzler, W.E. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 30, 97, 2002.
18. Sanchez, A.R., Sheridan, P.J., and Kupp, L.I. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 18, 93, 2003.
19. Grzesik, W.J., and Robey, P.G. Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J Bone Miner Res 9, 487, 1994.
20. Seiffert, D. Detection of vitronectin in mineralized bone matrix. J Histochem Cytochem 44, 275, 1996.
21. Hakeda, Y., Kawaguchi, H., Hurley, M., Pilbeam, C.C., Abreu, C., Linkhart, T.A., Mohan, S., Kumegawa, M., and Raisz, L.G. Intact insulin-like growth factor binding protein-5 (IGFBP-5) associates with bone matrix and the soluble fragments of IGFBP-5 accumulated in culture medium of neonatal mouse calvariae by parathyroid hormone and prostaglandin E2-treatment. J Cell Physiol 166, 370, 1996.
22. Franchimont, N., Gangji, V., Durant, D., and Canalis, E. Interleukin-6 with its soluble receptor enhances the expression of insulin-like growth factor-I in osteoblasts. Endocrinology 138, 5248, 1997.
23. Franchimont, N., Durant, D., and Canalis, E. Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures. Endocrinology 138, 3380, 1997.
24. Bautista, C.M., Baylink, D.J., and Mohan, S. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun 176, 756, 1991.
25. Andress, D.L., and Birnbaum, R.S. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 267, 22467, 1992.
26. Hollier, B., Harkin, D.G., Leavesley, D., and Upton, Z. Responses of keratinocytes to substrate-bound vitronectin: growth factor complexes. Exp Cell Res 305, 221, 2005.
27. Hyde, C., Hollier, B., Anderson, A., Harkin, D., and Upton, Z. Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration. J Invest Dermatol 122, 1198, 2004.
28. Kricker, J.A., Towne, C.L., Firth, S.M., Herington, A.C., and Upton, Z. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin. Endocrinology 144, 2807, 2003.
29. Dawson, R.A., Upton, Z., Malda, J., and Harkin, D.G. Preparation of cultured skin for transplantation using insulin-like growth factor I in conjunction with insulin-like growth factor binding protein 5, epidermal growth factor, and vitronectin. Transplantation 81, 1668, 2006.
30. Schleicher, I., Parker, A., Leavesley, D., Crawford, R., Upton, Z., and Xiao, Y. Surface modification by complexes of vitronectin and growth factors for serum-free culture of human osteoblasts. Tissue Eng 11, 1688, 2005.
31. Schoppet, M., Chavakis, T., Al-Fakhri, N., Kanse, S.M., and Preissner, K.T. Molecular interactions and functional interference between vitronectin and transforming growth factor-beta. Lab Invest 82, 37, 2002.
32. Kassem, M., Kveiborg, M., and Eriksen, E.F. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol. Eur J Clin Invest 30, 429, 2000.
33. Kveiborg, M., Flyvbjerg, A., Eriksen, E.F., and Kassem, M. Transforming growth factor-beta1 stimulates the production of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in human bone marrow stromal osteoblast progenitors. J Endocrinol 169, 549, 2001.
34. Conget, P.A., and Minguell, J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181, 67, 1999.
35. Salasznyk, R.M., Klees, R.F., Hughlock, M.K., and Plopper, G.E. ERK signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells on collagen I and vitronectin. Cell Commun Adhesion 11, 137, 2004.
36. Salasznyk, R.M., Williams, W.A., Boskey, A., Batorsky, A., and Plopper, G.E. Adhesion to vitronectin and collagen I promotes osteogenic differentiation of human mesenchymal stem cells. J Biomed Biotechnol 2004, 24, 2004.
37. Cheng, S.L., Zhang, S.F., Mohan, S., Lecanda, F., Fausto, A., Hunt, A.H., Canalis, E., and Avioli, L.V. Regulation of insulin-like growth factors I and II and their binding proteins in human bone marrow stromal cells by dexamethasone. J Cell Biochem 71, 449, 1998.
38. Andress, D.L. Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells. J Biol Chem 270, 28289, 1995.
39. Andress, D.L. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor. Am J Physiol 274, E744, 1998.
40. Andress, D.L. Comparison studies of IGFBP-5 binding to osteoblasts and osteoblast-derived extracellular matrix. Prog Growth Factor Res 6, 337, 1995.
41. Rasband, W.S. ImageJ 1.40d. National Institutes of Health., http://rsb.info.nih.gov/ij/ 1997-2004.
42. Collins, T. ImageJ for Microscopy. McMaster Biophotonics Facility. www.macbiophotonics.ca/imagej/. 2007.
43. Spinella-Jaegle, S., Roman-Roman, S., Faucheu, C., Dunn, F.W., Kawai, S., Gallea, S., Stiot, V., Blanchet, A.M., Courtois, B., Baron, R., and Rawadi, G. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation. Bone 29, 323, 2001.
44. Sternlicht, M.D., and Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Develop Biol 17, 463, 2001.
45. Blumenfeld, I., Srouji, S., Peled, M., and Livne, E. Metalloproteinases (MMPs-2, -3) are involved in TGF-beta and IGF-1-induced bone defect healing in 20-month-old female rats. Arch Gerontol Geriatr 35, 59, 2002.
46. Kujawa, M.J., Lennon, D.P., and Caplan, A.I. Growth and differentiation of stage 24 limb mesenchyme cells in a serum-free chemically defined medium. Exp Cell Res 183, 45, 1989.
47. Fukumoto, T., Sperling, J.W., Sanyal, A., Fitzsimmons, J.S., Reinholz, G.G., Conover, C.A., and O'Driscoll, S.W. Combined effects of insulin-like growth factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthritis Cartilage 11, 55, 2003.
48. Meuleman, N., Tondreau, T., Delforge, A., Dejeneffe, M., Massy, M., Libertalis, M., Bron, D., and Lagneaux, L. Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium. Eur J Haematol 76, 309, 2006.
49. Rousche, K.T., Ford, B.C., Praul, C.A., and Leach, R.M. The use of growth factors in the proliferation of avian articular chondrocytes in a serum-free culture system. Connect Tissue Res 42, 165, 2001.
50. Kveiborg, M., Flyvbjerg, A., and Kassem, M. Synergistic effects of 1, 25-dihydroxyvitamin D3 and TGF-beta1 on the production of insulin-like growth factor binding protein 3 in human bone marrow stromal cell cultures. Acta Pathol Microbiol Immunol Scand 110, 410, 2002.
51. Scaffidi, A.K., Petrovic, N., Moodley, Y.P., Fogel-Petrovic, M., Kroeger, K.M., Seeber, R.M., Eidne, K.A., Thompson, P.J., and Knight, D.A. Alpha(v)beta(3) integrin interacts with the transforming growth factor beta (TGFbeta) type II receptor to potentiate the proliferative effects of TGFbeta1 in living human lung fibroblasts. J Biol Chem 279, 37726, 2004.
52. Jia, D., and Heersche, J.N. Insulin-like growth factor-1 and -2 stimulate osteoprogenitor proliferation and differentiation and adipocyte formation in cell populations derived from adult rat bone. Bone 27, 785, 2000.
53. Walsh, S., Jefferiss, C.M., Stewart, K., and Beresford, J.N. IGF-I does not affect the proliferation or early osteogenic differentiation of human marrow stromal cells. Bone 33, 80, 2003.
54. Nam, T., Moralez, A., and Clemmons, D. Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actions. Endocrinology 143, 30, 2002.
55. Hurley, M.M., Abreu, C., Gronowicz, G., Kawaguchi, H., and Lorenzo, J. Expression and regulation of basic fibroblast growth factor mRNA levels in mouse osteoblastic MC3T3-E1 cells. J Biol Chem 269, 9392, 1994.
56. Karsdal, M.A., Fjording, M.S., Foged, N.T., Delaisse, J.M., and Lochter, A. Transforming growth factor-beta-induced osteoblast elongation regulates osteoclastic bone resorption through a p38 mitogen-activated protein kinaseand matrix metalloproteinase-dependent pathway. J Biol Chem 276, 39350, 2001.
57. Boehm, J.R., Kutz, S.M., Sage, E.H., Staiano-Coico, L., and Higgins, P.J. Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-beta1. J Cell Physiol 181, 96, 1999.
58. Kutz, S.M., Hordines, J., McKeown-Longo, P.J., and Higgins, P.J. TGF-beta1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion. J Cell Sci 114, 3905, 2001.
59. Czekay, R.P., Aertgeerts, K., Curriden, S.A., and Loskutoff, D.J. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. J Cell Biol 160, 781, 2003.
60. Tram, K.K., Murray, S.S., Lee, D.B., and Murray, E.J. PTH-induced osteoblast contraction is mediated by cysteine proteases. Kidney Int 43, 693, 1993.
61. Bafetti, L.M., Young, T.N., Itoh, Y., and Stack, M.S. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. J Biol Chem 273, 143, 1998.
62. Rolli, M., Fransvea, E., Pilch, J., Saven, A., and Felding-Habermann, B. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci U S A 100, 9482, 2003.
63. Brooks, P.C., Stromblad, S., Sanders, L.C., von Schalscha, T.L., Aimes, R.T., Stetler-Stevenson, W.G., Quigley, J.P., and Cheresh, D.A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85, 683, 1996.
64. Ray, J.M., and Stetler-Stevenson, W.G. Gelatinase A activity directly modulates melanoma cell adhesion and spreading. Embo J 14, 908, 1995.